Market Value188,647,000
Total Holdings63
File Date2020-11-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
LYRA / Lyra Therapeutics, Inc.
BHVN / Biohaven Ltd.
US2103731061 / Constellation Pharmaceuticals Inc
RVNC / Revance Therapeutics, Inc.
VAPO / Vapotherm, Inc.
AGLE / Aeglea BioTherapeutics Inc
COGT / Cogent Biosciences, Inc.
RLMD / Relmada Therapeutics, Inc.
RAPT / RAPT Therapeutics, Inc.
PRTA / Prothena Corporation plc
MASI / Masimo Corporation
IONS / Ionis Pharmaceuticals, Inc.
MDNA / Medicenna Therapeutics Corp
US457669AA77 / Insmed Inc Bond
AXNX / Axonics, Inc.
AFMD / Affimed N.V.
MRSN / Mersana Therapeutics, Inc.
IRTC / iRhythm Technologies, Inc.
TARA / Protara Therapeutics, Inc.
OSH / Oak Street Health Inc
ATRS / Antares Pharma Inc
ZYXI / Zynex, Inc.
/ Immunomedics, Inc.
PRVB / Provention Bio Inc
QDEL / QuidelOrtho Corporation
NVRO / Nevro Corp.
ZYME / Zymeworks Inc.
ZYME / Zymeworks Inc. Put
BPMC / Blueprint Medicines Corporation
DVAX / Dynavax Technologies Corporation
EIGR / Eiger BioPharmaceuticals, Inc.
INSP / Inspire Medical Systems, Inc.
LRMR / Larimar Therapeutics, Inc.
MSON / Misonix Inc
AXGN / Axogen, Inc.
SRDX / Surmodics, Inc.
STAA / STAAR Surgical Company
HARP / Harpoon Therapeutics, Inc.
KDMN / Kadmon Holdings Inc
KYMR / Kymera Therapeutics, Inc.
RFL / Rafael Holdings, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
PCRX / Pacira BioSciences, Inc.
SRPT / Sarepta Therapeutics, Inc.
ISEE / IVERIC bio Inc
US38341PAA03 / Gossamer Bio Inc
MRK / Merck & Co., Inc.
TRIL / Trillium Therapeutics Inc
OSUR / OraSure Technologies, Inc.
ARNA / Arena Pharmaceuticals Inc
CRDF / Cardiff Oncology, Inc.
NVCR / NovoCure Limited
TCRR / Tcr2 Therapeutics Inc
BIIB / Biogen Inc.
PAYX / Paychex, Inc.
HZNP / Horizon Therapeutics Plc
CRSP / CRISPR Therapeutics AG
ADVM / Adverum Biotechnologies, Inc.
LNTH / Lantheus Holdings, Inc.
DXCM / DexCom, Inc.
CSTL / Castle Biosciences, Inc.
PIRS / Pieris Pharmaceuticals, Inc.
FATE / Fate Therapeutics, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
HUM / Humana Inc.
VCEL / Vericel Corporation
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
PODD / Insulet Corporation
ARVN / Arvinas, Inc.
LLY / Eli Lilly and Company
NTRA / Natera, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
NARI / Inari Medical, Inc.
EPIX / ESSA Pharma Inc.
IRMD / IRADIMED CORPORATION
XENE / Xenon Pharmaceuticals Inc.
SILK / Silk Road Medical, Inc
INBX / Inhibrx Biosciences, Inc.
FOLD / Amicus Therapeutics, Inc.
ABBV / AbbVie Inc.